Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells

Mycological Research

Volumn 113, Issue 3, 2009, Pages 388-390

  Yang, Yun Liang ^a   Wang, Chih Wei ^b   Chen, Chiung Tong ^b   Wang, Min Hsien ^b   Hsiao, Chin Fu ^b   Lo, Hsiu Jung ^b  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Candida albicans; Mouse model; Protection; Virulence

Indexed keywords

CPH1 PROTEIN, CANDIDA ALBICANS; DNA BINDING PROTEIN; EFG1 PROTEIN, CANDIDA ALBICANS; FUNGAL PROTEIN; TRANSCRIPTION FACTOR;

CYTOLOGY; FUNGAL DISEASE; FUNGUS; IMMUNE SYSTEM; MUTATION; RODENT; VIRULENCE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANDIDA ALBICANS; CANDIDIASIS; GENETICS; IMMUNIZATION; IMMUNOLOGY; MALE; MICROBIOLOGY; MOUSE; PATHOGENICITY;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; DNA-BINDING PROTEINS; FUNGAL PROTEINS; IMMUNIZATION, SECONDARY; MALE; MICE; MICE, INBRED BALB C; TRANSCRIPTION FACTORS;

CANDIDA ALBICANS; MUS;

EID: 60849102762     PISSN: 09537562     EISSN: 14698102     Source Type: Journal    
DOI: 10.1016/j.mycres.2008.11.016     Document Type: Article

References (10)

1. Bistoni F., Vecchiarelli A., Cenci E., Puccetti P., Marconi P., and Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun 51 (1986) 668-674
2. Chen C.G., Yang Y.L., Cheng H.H., Su C.L., Huang S.F., Chen C.T., Liu Y.T., Su I.J., and Lo H.J. Non-lethal Candida albicans cph1/cph1 efg1/efg1 transcription factor mutant establishing restricted zone of infection in a mouse model of systemic infection. Int J Immunopathol Pharmacol 19 (2006) 561-565
3. Fernandez-Arenas E., Molero G., Nombela C., Diez-Orejas R., and Gil C. Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine. Proteomics 4 (2004) 3007-3020
4. Gillum A.M., Tsay E.Y., and Kirsch D.R. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198 (1984) 179-182
5. Lo H.J., Kohler J.R., DiDomenico B., Loebenberg D., Cacciapuoti A., and Fink G.R. Nonfilamentous C. albicans mutants are avirulent. Cellule 90 (1997) 939-949
6. Pappas P.G., Rex J.H., Lee J., Hamill R.J., Larsen R.A., Powderly W., Kauffman C.A., Hyslop N., Mangino J.E., Chapman S., Horowitz H.W., Edwards J.E., and Dismukes W.E. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37 (2003) 634-643
7. Sherman F. Getting started with yeast. Meth Enzymol 350 (2002) 3-41
8. Vecchiarelli A., Cenci E., Puliti M., Blasi E., Puccetti P., Cassone A., and Bistoni F. Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state. Cell Immunol 124 (1989) 334-344
9. White T.C., Marr K.A., and Bowden R.A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11 (1998) 382-402
10. Yang Y.L., and Lo H.J. Mechanisms of antifungal agent resistance. J Microbiol Immunol Infect 34 (2001) 79-86